Latest in Research & Development

BioMarin Pharmaceutical expands Cork targeted therapy manufacturing facility with new lab

The Irish facility is responsible for the development and commercialisation of therapies that address genetic conditions, and this expansion will allow the company to enhance its approved medicine production capacity

Find out more

IFF Pharma Solutions launches customer experience platform, AnswerCenter

AnswerCenter is part of IFF's ongoing digitalisation initiative, allowing customers to easily access tailored pharmaceutical excipient solutions
See more

Neuraxpharm Group and Pharmathen partner to develop long-lasting psychiatric injectables

The co-development deal aims to enhance patient compliance, with Pharmathen and Neuraxpharm holding rights to the product in North America and Europe, respectively

Bespak and OzUK extend their joint capacity in early-stage pMDI development

The partnership will streamline the pMDI development, testing and pilot scale manufacturing processes to rapidly progress inhaled therapeutics into clinical trials

Concept and Accelero Biostructures accelerate early drug discovery with X-ray crystallography

The companies will incorporate their X-ray crystallography and drug discovery technologies to offer clients rapid hit-to-lead drug development

Thermo Fisher Scientific officially opens US oral solid dose testing and R&D facility

The company's further expansion in the Bend, Oregon area will assist its pharmaceutical clients in the early development of oral solid dosage (OSD) forms

First patient dosed in Phase I trial with a PARP1 selective inhibitor to treat solid tumours

Duke Street Bio is pleased to announce that the first patient has been dosed in a Phase I trial evaluating the highly selective PARP1 inhibitor, DSB2455, in patients with solid tumours

Alanis Therapeutics chooses KBI Biopharma to develop and produce its lead antibody

KBI will be responsible for development, process optimisation and manufacture of the therapeutic monoclonal antibody, which could be used to treat certain haematological malignancies

Merck's sacituzumab tirumotecan granted Breakthrough Therapy Designation by the FDA

The antibody-drug conjugate (ADC) can be used to treat patients with advanced or metastatic non-small cell lung cancer (NSCLC)

The new F-Gas Regulation and its impact on pharmaceutical freeze-drying

Freeze-drying or lyophilization represents a pivotal process in the life sciences industry. During the past five decades, the technology involved has evolved into a complex, integrated system that balances both technical and biological specifications with economic, safety, and environmental concerns

Latest posts in Research & Development

Quantoom Biosciences, Univercells and Fiocruz collaborate to advance global RNA vaccine development

Together, the companies will develop RNA-based biopharmaceuticals, while also building a dedicated mRNA production facility in Brazil

US Pharmacopeia details mass spectrometry guidelines to advance biologics impurity control

The new chapter aims to standardise the use of mass spectrometry-based analysis in the biopharmaceutical industry, which can be used to detect impurities in cell and gene therapies, antibodies and other biologics
You need to be a subscriber to read this article.
Click here to find out more.

Hybrid interferons: developing a novel drug class

With many hurdles to overcome, establishing a new drug candidate is a long process — particularly if you are a smaller biotech company with limited resources. These challenges can be further amplified if the candidate being developed is of an entirely novel drug class

2BScientific expands its life science product supply service to Europe with new German facility

The facility in Munich will serve the European market with life science products, including in vitro diagnostic (IVD) reagents, buffers, biomaterials and antibodies

Roche acquires clinical-stage biopharmaceutical company Poseida Therapeutics

Through the merger, Roche will acquire Poseida's allogeneic CAR-T cell therapy portfolio, including pre-clinical and clinical-stage iterations for a range of conditions

Aurobindo Pharma signs $25m respiratory drug development and commercialisation deal with global pharma company

The companies will co-develop and commercialise respiratory therapeutics, diversifying Aurobindo's current portfolio

Steritas and argenx join forces to advance steroid-sparing therapeutic development

With the help of Steritas' STOX Suite, argenx aims to develop antibody-based therapeutics for immune diseases, potentially allowing patients to move away from chronic steroid usage

Sartorius Stedim Biotech supports bioprocess development with new Innovation Centre

The Massachusetts, US-based Centre for Bioprocess Innovation is a collaborative space designed to develop and optimise biomanufacturing processes

BioPharmaSpec expands its biopharma discovery and preclinical capabilities with three new facilities

The contract research organisation (CRO) has expanded its European presence with three facilities, which are catered for biopharmaceutical drug discovery and preclinical characterisation

Transmission Raman Spectroscopy - access the webinar series today

Offering significant advantages for bulk, quantitative and non-destructive analysis, Transmission Raman Spectroscopy is a preferred choice for applications where surface analysis is insufficient or prone to errors. Speakers from Agilent, Novartis Pharma, AstraZeneca, Bristol-Myers Squibb and AbbVie go deeper in this FREE webinar series

Syncona launches early-stage drug development company, Slingshot Therapeutics

The novel early-stage pharmaceutical company aims to collaborate with academic institutions to bring their findings to the clinic, with their first programme centring around inflammatory disease

Medac and chiron develop organ-on chip tech for animal free drug testing

The companies aim to develop an animal-free pharmaceutical testing method that utilises organ-on chip technology, and will be used in rheumatoid arthritis drug testing

Sponsor content

Isopod rapid cleanrooms helping life science start-ups and smaller businesses grow

The Guardtech Group’s quick-assembly pods provide a fast, high-quality cleanroom solution

Asahi Kasei Pharma grows its global portfolio with anti-CX3CR1 license

The licensing deal with Chiome enhances its open innovation platform

SPT Labtech integrates barcode scanner with elabnext platform

New tool boosts sample tracking and data integrity in life science labs

Solvent recycler SPR-200 boosts sustainability in pharma labs

Recycling up to 90% of solvent in isocratic HPLC improves lab efficiency and sustainability

Biocair strengthens its customer focus in 2024 and prepares for another year of growth

Logistics leader launches new customer portal and expands global footprint

New Sicco desiccators and drying cabinets guide available now

Flexible and robust solutions for drying and storage

Photocatalysed flow method accelerates synthesis of potent MC4R antagonist

New automated continuous flow synthesis of spirocyclic tetrahydronaphthyridines for drug discovery

Vapourtec introduces benchtop synthesiser for peptide production

Peptide-Builder combines automation and efficiency to minimise solvent use

Thermo Fisher Scientific introduces CTS Detachable Dynabeads for cell therapy production

New products enable precise T cell isolation, advancing CAR-T therapy development

Modular automated flow synthesis of spirocyclic THNs from primary alkylamines

Asynt and the Cresswell Group achieve advances in drug discovery scaffolds

Guardtech Group hoping to end golden year with more success at SME National Business Awards

Suffolk contamination control experts looking to add Best Enterprising Business prize to epic 2024 awards haul at glitzy Wembley Stadium showpiece on 6 December

ACG launches ADAPT X at CPhI & PMEC India 2024

Innovative tablet feeder sets new benchmarks for efficiency and versatility in pharmaceutical packaging solutions

Featured companies

At Biotech Fluidics, our aim is to help you make your analytical work more effective and reliable. Contract development and manufacturing of Potent and non Potent APIs PCI Pharma Services: Your bridge between life-changing therapies and patients. Quotient Sciences is a drug development and manufacturing accelerator providing integrated services across the entire development pathway for small-molecule and peptide drug...
See more